Epidemiology of Atherosclerosis

Clinical Trial ID NCT00005147

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00005147

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping. I. Basic theory and an analysis of alcohol dehydrogenase activity in Drosophila. Genetics 1987 6.31
2 Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988 6.01
3 The use of measured genotype information in the analysis of quantitative phenotypes in man. I. Models and analytical methods. Ann Hum Genet 1986 5.02
4 Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 1985 3.81
5 The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individuals. Am J Med Genet 1987 3.57
6 Bias of the contribution of single-locus effects to the variance of a quantitative trait. Am J Hum Genet 1986 1.65
7 Identifying pedigrees segregating at a major locus for a quantitative trait: an efficient strategy for linkage analysis. Am J Hum Genet 1989 1.62
8 Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. N Engl J Med 1983 1.56
9 Management of lipids in primary and secondary prevention of cardiovascular diseases. Mayo Clin Proc 1988 1.42
10 Estimation of genetic model parameters: variables correlated with a quantitative phenotype exhibiting major locus inheritance. Genet Epidemiol 1989 1.40
11 Genetic determination of plasma apolipoprotein AI in a population-based sample. Am J Hum Genet 1989 1.29
12 Distribution of sodium-lithium countertransport and blood pressure in Caucasians five to eighty-nine years of age. Hypertension 1989 1.28
13 The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN. I. Pleiotropic effects on means and variances. Am J Hum Genet 1991 1.25
14 Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. Arterioscler Thromb 1991 1.22
15 Expressed hypervariable polymorphism of apolipoprotein (a). Am J Hum Genet 1991 1.20
16 The use of measured genotype information in the analysis of quantitative phenotypes in man. III. Simultaneous estimation of the frequencies and effects of the apolipoprotein E polymorphism and residual polygenetic effects on cholesterol, betalipoprotein and triglyceride levels. Ann Hum Genet 1987 1.16
17 The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minnesota. II. Regression relationships with concomitants. Am J Hum Genet 1992 1.16
18 The genetic determination of plasma apolipoprotein A-I levels measured by radioimmunoassay: a study of high-risk pedigrees. Am J Hum Genet 1986 1.11
19 Apolipoproteins and coronary artery disease. Mayo Clin Proc 1986 1.11
20 Application of cladistics to the analysis of genotype-phenotype relationships. Eur J Epidemiol 1992 1.04
21 Genetic architecture of inter-individual variability in apolipoprotein, lipoprotein and lipid phenotypes. Ciba Found Symp 1987 1.03
22 Univariate and bivariate analyses of cholesterol and triglyceride levels in pedigrees. Am J Med Genet 1986 1.00
23 Partitioning the variability of fasting plasma glucose levels in pedigrees. Genetic and environmental factors. Am J Epidemiol 1987 0.98
24 Evidence that a single gene with gender- and age-dependent effects influences systolic blood pressure determination in a population-based sample. Am J Hum Genet 1991 0.97
25 Genetics of atherosclerosis. Annu Rev Genet 1990 0.97
26 Detection of genetic heterogeneity among pedigrees through complex segregation analysis: an application to hypercholesterolemia. Am J Hum Genet 1984 0.94
27 Genetic studies of human apolipoproteins. XV. An overview of IEF immunoblotting methods to screen apolipoprotein polymorphisms. Hum Hered 1990 0.94
28 Levels of lipids, lipoproteins, and apolipoproteins in a defined population. Mayo Clin Proc 1991 0.93
29 The effects of generation and gender on the joint distributions of lipid and apolipoprotein phenotypes in the population at large. J Clin Epidemiol 1990 0.92
30 Estimation of the frequency of isoform-genotype discrepancies at the apolipoprotein E locus in heterozygotes for the isoforms. Genet Epidemiol 1992 0.89
31 Total cholesterol and lipoproteins in school children: prediction of coronary heart disease in adult relatives. Circulation 1983 0.89
32 Phenotypic effects of apolipoprotein structural variation on lipid profiles. III. Contribution of apolipoprotein E phenotype to prediction of total cholesterol, apolipoprotein B, and low density lipoprotein cholesterol in the healthy women study. Arteriosclerosis 1990 0.89
33 A rapid apolipoprotein E radioimmunoassay using solid-phase staphylococcus protein. Use of pooled plasma as a secondary standard. Biochem Biophys Res Commun 1986 0.87
34 Genetics of primary hypertension. Clin Exp Hypertens A 1986 0.87
35 Use of a quality-control plasma sample to decrease interassay variation in radioimmunoassays of apolipoprotein A-I. Clin Chem 1986 0.85
36 Strategies for elucidating the phenotypic and genetic heterogeneity of a chronic disease with a complex etiology. Prog Clin Biol Res 1985 0.85
37 Insulinemia in children at low and high risk of NIDDM. Diabetes Care 1993 0.85
38 Smoking and reverse cholesterol transport: evidence for gene-environment interaction. Clin Genet 1989 0.84
39 An application of a model for a genotype-dependent relationship between a concomitant (age) and a quantitative trait (LDL cholesterol) in pedigree data. Genet Epidemiol 1984 0.83
40 Genetic studies of human apolipoproteins. XIII. Quantitative polymorphism of apolipoprotein C-III in the Mayans of the Yucatán Peninsula. Hum Hered 1990 0.81
41 Quantification and immunolocalization of apolipoprotein E in experimental atherosclerosis. Atherosclerosis 1986 0.80
42 Quantification of human plasma apolipoproteins C-I, C-II, and C-III by radioimmunoassays. Mayo Clin Proc 1993 0.79
43 Sodium-lithium countertransport genotype and the probability of hypertension in adults. Hypertension 1993 0.77
44 Sodium-lithium countertransport and hypertension in Rochester, Minnesota. Hypertension 1991 0.77
45 Genetic studies of human apolipoproteins. XVI. APOE polymorphism and cholesterol levels in the Mayans of the Yucatan Peninsula, Mexico. Clin Genet 1991 0.76
46 Sodium-lithium countertransport and probability of hypertension in Caucasians 47 to 89 years old. Hypertension 1992 0.76
47 Genetic studies of human apolipoproteins: XIV. A simple agarose isoelectric focusing gel method for apolipoprotein E phenotyping. Electrophoresis 1990 0.75
48 Genetic studies of human apolipoproteins. XVII: Population genetics of apolipoprotein polymorphisms in American Samoa. Am J Phys Anthropol 1991 0.75
49 Apolipoprotein B quantified by particle-concentration fluorescence immunoassay. Clin Chem 1992 0.75
50 Plasma lipids and apolipoprotein A-I and A-II levels in alcoholic patients. Am J Clin Nutr 1986 0.75
51 Effect of 25-hydroxycholesterol and bile acids on the regulation of cholesterol metabolism in Hep G2 cells. Biochem J 1989 0.75
52 Lipid and apolipoprotein levels in six Solomon Island societies differ from those in a U.S. white population. Am J Phys Anthropol 1990 0.75
Next 100